Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?
Mazzone E, Knipper S, Mistretta FA, Tian Z, Preisser F, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.
Mazzone E, et al. Among authors: knipper s.
Cancer Epidemiol. 2019 Feb;58:83-88. doi: 10.1016/j.canep.2018.11.007. Epub 2018 Dec 6.
Cancer Epidemiol. 2019.
PMID: 30528834